Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab

Zeitschrift für Gastroenterologie
M A StangeH Wedemeyer

Abstract

Hepatitis B virus reactivation during immunosuppressive therapies can lead to liver failure with very limited treatment options available. We report here on two cases of severe hepatitis B reactivation during chemotherapy including rituximab for B cell lymphoma which were treated with liver or liver-cell transplantation. Liver function was normal and HBV infection was unknown in both patients before chemotherapy was started. Impaired liver function became apparent after 4 and 6 courses of chemotherapy, respectively, and both patients experienced fulminant hepatic failure despite antiviral treatment with lamivudine or entecavir. Patient A underwent liver transplantation after documentation of complete remission of the lymphoma and survived without any evidence for hepatitis B recurrence. Patient B received 4 courses of hepatocyte transplantation but did not survive. These cases underline the importance of anti-HBc screening in patients receiving immunosuppressive treatments in particular when rituximab is given. Pre-emptive antiviral treatments should be administered since delayed antiviral treatment is frequently unable to prevent liver failure.

Citations

Dec 2, 2010·Clinical Rheumatology·Annette F JanssonVeit Grote
Nov 19, 2010·World Journal of Gastroenterology : WJG·Sylvia BrostChristoph Eisenbach
Jul 30, 2011·World Journal of Gastroenterology : WJG·Timothée NoterdaemeOlivier Detry
May 8, 2014·World Journal of Gastroenterology : WJG·Wei-Ping LiuJun Zhu
Jun 4, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Andrzej TarantaKarsten Wursthorn
Jun 10, 2014·Expert Opinion on Biological Therapy·Mauro ViganòPietro Lampertico
Nov 22, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Hans L TillmannGeorge N Dalekos
Jan 5, 2011·Pharmazie in unserer Zeit·Markus Cornberg, Michael P Manns
Oct 26, 2013·Transplantation Proceedings·J M KimS-K Lee
Apr 19, 2016·Expert Opinion on Biological Therapy·Viganò MauroPietro Lampertico
Jun 29, 2018·Expert Review of Clinical Immunology·Nicolò Pipitone, Carlo Salvarani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.